Literature DB >> 28592540

Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.

Shridhar Bale1, Geraldine Goebrecht1, Armando Stano1, Richard Wilson2, Takayuki Ota1, Karen Tran2, Jidnyasa Ingale1, Michael B Zwick1, Richard T Wyatt3,2,4.   

Abstract

We have demonstrated that a liposomal array of well-ordered trimers enhances B cell activation, germinal center formation, and the elicitation of tier-2 autologous neutralizing antibodies. Previously, we coupled well-ordered cleavage-independent NFL trimers via their C-terminal polyhistidine tails to nickel lipids integrated into the lipid bilayer. Despite favorable in vivo effects, concern remained over the potentially longer-term in vivo instability of noncovalent linkage of the trimers to the liposomes. Accordingly, we tested both cobalt coupling and covalent linkage of the trimers to the liposomes by reengineering the polyhistidine tail to include a free cysteine on each protomer of model BG505 NFL trimers to allow covalent linkage. Both cobalt and cysteine coupling resulted in a high-density array of NFL trimers that was stable in both 20% mouse serum and 100 mM EDTA, whereas the nickel-conjugated trimers were not stable under these conditions. Binding analysis and calcium flux with anti-Env-specific B cells confirmed that the trimers maintained conformational integrity following coupling. Following immunization of mice, serologic analysis demonstrated that the covalently coupled trimers elicited Env-directed antibodies in a manner statistically significantly improved compared to soluble trimers and nickel-conjugated trimers. Importantly, the covalent coupling not only enhanced gp120-directed responses compared to soluble trimers, it also completely eliminated antibodies directed to the C-terminal His tag located at the "bottom" of the spike. In contrast, soluble and noncovalent formats efficiently elicited anti-His tag antibodies. These data indicate that covalent linkage of well-ordered trimers to liposomes in high-density array displays multiple advantages in vitro and in vivoIMPORTANCE Enveloped viruses typically encode a surface-bound glycoprotein that mediates viral entry into host cells and is a primary target for vaccine design. Liposomes with modified lipid head groups have a unique feature of capturing and displaying antigens on their surfaces, mimicking the native pathogens. Our first-generation nickel-based liposomes captured HIV-1 Env glycoprotein trimers via a noncovalent linkage with improved efficacy over soluble glycoprotein in activating germinal center B cells and eliciting tier-2 autologous neutralizing antibodies. In this study, we report the development of second-generation cobalt- and maleimide-based liposomes that have improved in vitro stability over nickel-based liposomes. In particular, the maleimide liposomes captured HIV-1 Env trimers via a more stable covalent bond, resulting in enhanced germinal center B cell responses that generated higher antibody titers than the soluble trimers and liposome-bearing trimers via noncovalent linkages. We further demonstrate that covalent coupling prevents release of the trimers prior to recognition by B cells and masks a nonneutralizing determinant located at the bottom of the trimer.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; antibody repertoire; human immunodeficiency virus; immunization; immunology; liposomes; nanoparticles; pathogens; vaccines

Mesh:

Substances:

Year:  2017        PMID: 28592540      PMCID: PMC5533919          DOI: 10.1128/JVI.00443-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.

Authors:  Hong Shen; Anne L Ackerman; Virginia Cody; Alessandra Giodini; Ella R Hinson; Peter Cresswell; Richard L Edelson; W Mark Saltzman; Douglas J Hanlon
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

Review 2.  Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

Authors:  Yvonne Perrie; Afzal R Mohammed; Daniel J Kirby; Sarah E McNeil; Vincent W Bramwell
Journal:  Int J Pharm       Date:  2008-04-30       Impact factor: 5.875

3.  Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions.

Authors:  Matthew Wright
Journal:  Methods Mol Biol       Date:  2012

Review 4.  Reengineering viruses and virus-like particles through chemical functionalization strategies.

Authors:  Mark Thomas Smith; Anna K Hawes; Bradley Charles Bundy
Journal:  Curr Opin Biotechnol       Date:  2013-03-04       Impact factor: 9.740

Review 5.  Application of surface-linked liposomal antigens to the development of vaccines that induce both humoral and cellular immunity.

Authors:  Tetsuya Uchida; Maiko Taneichi
Journal:  Jpn J Infect Dis       Date:  2014       Impact factor: 1.362

6.  Anti-HIV B Cell lines as candidate vaccine biosensors.

Authors:  Takayuki Ota; Colleen Doyle-Cooper; Anthony B Cooper; Michael Huber; Emilia Falkowska; Katherine J Doores; Lars Hangartner; Khoa Le; Devin Sok; Joseph Jardine; Jeffrey Lifson; Xueling Wu; John R Mascola; Pascal Poignard; James M Binley; Bimal K Chakrabarti; William R Schief; Richard T Wyatt; Dennis R Burton; David Nemazee
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

7.  Hock immunization: a humane alternative to mouse footpad injections.

Authors:  T Kamala
Journal:  J Immunol Methods       Date:  2007-08-28       Impact factor: 2.303

8.  Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination.

Authors:  Sharmila Pejawar-Gaddy; James M Kovacs; Dan H Barouch; Bing Chen; Darrell J Irvine
Journal:  Bioconjug Chem       Date:  2014-07-14       Impact factor: 4.774

Review 9.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

Review 10.  Why HIV virions have low numbers of envelope spikes: implications for vaccine development.

Authors:  John Schiller; Bryce Chackerian
Journal:  PLoS Pathog       Date:  2014-08-07       Impact factor: 6.823

View more
  34 in total

Review 1.  Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

Authors:  P J Klasse; Gabriel Ozorowski; Rogier W Sanders; John P Moore
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

Review 2.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

3.  Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity.

Authors:  Sebastian Ols; Lifei Yang; Elizabeth A Thompson; Pradeepa Pushparaj; Karen Tran; Frank Liang; Ang Lin; Bengt Eriksson; Gunilla B Karlsson Hedestam; Richard T Wyatt; Karin Loré
Journal:  Cell Rep       Date:  2020-03-24       Impact factor: 9.423

4.  Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers.

Authors:  Talar Tokatlian; Benjamin J Read; Christopher A Jones; Daniel W Kulp; Sergey Menis; Jason Y H Chang; Jon M Steichen; Sudha Kumari; Joel D Allen; Eric L Dane; Alessia Liguori; Maya Sangesland; Daniel Lingwood; Max Crispin; William R Schief; Darrell J Irvine
Journal:  Science       Date:  2018-12-20       Impact factor: 47.728

5.  Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes.

Authors:  Daniel P Leaman; Armando Stano; Yajing Chen; Lei Zhang; Michael B Zwick
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

Review 6.  Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases.

Authors:  Lampouguin Yenkoidiok-Douti; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2020-01-12

7.  Glutaraldehyde Cross-linking of HIV-1 Env Trimers Skews the Antibody Subclass Response in Mice.

Authors:  Martina Soldemo; Monika Àdori; Julian M Stark; Yu Feng; Karen Tran; Richard Wilson; Lifei Yang; Javier Guenaga; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

Review 8.  Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines.

Authors:  Lantian Lu; Viet Tram Duong; Ahmed O Shalash; Mariusz Skwarczynski; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2021-05-28

9.  Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery.

Authors:  David Peterhoff; Stefanie Thalhauser; Jan M Sobczak; Mona O Mohsen; Christoph Voigt; Nicole Seifert; Patrick Neckermann; Alexandra Hauser; Song Ding; Quentin Sattentau; Martin F Bachmann; Miriam Breunig; Ralf Wagner
Journal:  Vaccines (Basel)       Date:  2021-06-11

Review 10.  Factors in B cell competition and immunodominance.

Authors:  Robert K Abbott; Shane Crotty
Journal:  Immunol Rev       Date:  2020-06-01       Impact factor: 10.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.